Current Studies

MEU204 - Evaluation of a new nasal spray medication for the treatment of asthma

MEU204 - Evaluation of a new nasal spray medication for the treatment of asthma

Study CodeMEU204
Study TypeAsthma
Key InclusionsBlue inhaler users, Males and Females ages 18 to 55.
Key ExclusionsSteroid Inhaler users, Current smokers, chest infections within the past month. History of nasal deformaty (broken nose, polyps etc)
Expenses£2800.00
Number of Visits20

MEU203 - A potential new treatment for asthma in tablet form.

MEU203 - A potential new treatment for asthma in tablet form.

Study CodeMEU203
Study TypeAsthma
Key InclusionsMales and females 18 to 65 with a diagnosis of asthma who currently use a steroid inhaler
Key ExclusionsFemales of child bearing potential. History of heart failure, antihistamine users
Expenses£520.00
Number of Visits7

MEU202 - Evaluation of a potential new treatment for COPD which has been previously tested at the MEU showing positive effects.

MEU202 - Evaluation of a potential new treatment for COPD which has been previously tested at the MEU showing positive effects.

Study CodeMEU202
Study TypeCOPD
Key InclusionsMales and females aged 40 to 75 with a clinical diagnosis of COPD.
Key ExclusionsCold, flu, chest infection in the last 6 weeks prior to the study. Changes to COPD medications in the past 3 months. Prostate problems.
Expenses£2180.00
Number of Visits9

TRF Study - Evaluation of a new inhaler device for COPD

TRF Study - Evaluation of a new inhaler device for COPD

Study CodeTRF
Study TypeCOPD
Key InclusionsCOPD worsening in the past 12 months treated with steroids or antibiotics, Aged over 40, Smoking history greater than 10 years
Key ExclusionsUncontrolled heart conditions, drug or food allergies, worsening of COPD symptoms in the past 2 weeks, Peptic ulcers, sleep apnoea
Expenses£0.00
Number of Visits11

MEU205 - Evaluation of a new medication in the form of an inhaler and also injection. The study medication has been previously tested in patients showing to be effective.

MEU205 - Evaluation of a new medication in the form of an inhaler and also injection. The study medication has been previously tested in patients showing to be effective.

Study CodeMEU205
Study TypeHealthy Volunteer
Key InclusionsHealthy Men and Women aged 18 to 65 who are not taking any prescribed medications
Key ExclusionsAny current illness such as heart conditions, diabetes, epilepsy, asthma, thyroid problems. People using prescription or over the counter medications currently.
Expenses£885.00
Number of Visits5

We are one of the UK's leading clinical research units and we have studies running throughout the year. If you are interested in becoming a volunteer with us then please complete our online enquiry form or call our friendly Volunteer Services team on 0800 655 6553.

Volunteer

Group of young people